Krishnaswamy Srinivas Raghavan

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishnaswamy Srinivas Raghavan. Retrieved from https://idiyas.com/inventor/krishnaswamy-srinivas-raghavan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 70.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 119(Granted Patents)

Company Filing History:

10 out of 3,737

Bristol-Myers Squibb Compnay

patents

Years Active: 2001-2014

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8632788 - Parenteral formulation for epothilone analogs (2014-01-21),

2. 8252821 - Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound (2012-08-28),

3. RE40387 - Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones (2008-06-16),

4. 7053069 - Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives (2006-05-30),

5. 7022330 - Parenteral formulation for epothilone analogs (2006-04-04),

6. 6670384 - Methods of administering epothilone analogs for the treatment of cancer (2003-12-30),

7. 6589955 - Pediatric formulation of gatifloxacin (2003-07-08),

8. 6576651 - Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones (2003-06-10),

9. 6413969 - Gatifloxacin pentahydrate (2002-07-02),

10. 6218375 - Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-&bgr;-cyclodextrin or 2-hydroxypropyl-&bgr;-cyclodextrin and method (2001-04-17),

Title: Innovations of Krishnaswamy Srinivas Raghavan

Introduction

Krishnaswamy Srinivas Raghavan is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 10 patents. His work focuses on innovative formulations that enhance the delivery and efficacy of therapeutic compounds.

Latest Patents

Among his latest patents is a parenteral formulation for epothilone analogs. This process involves dissolving the analog in a mixture of at least 50% by volume tertiary-butanol in water, followed by lyophilization. The resulting product is packaged in a vial with a solvent comprising anhydrous ethanol and a suitable nonionic surfactant. In practice, the contents of the diluent vial are added to the lyophilized product to create a solution for intravenous injection. Another significant patent is for bioavailable capsule compositions of an amorphous alpha-(N-sulfonamido)acetamide compound. This composition includes various excipients such as polyethylene glycol and Vitamin E polyethylene glycol succinate, aimed at improving the bioavailability of the active compound.

Career Highlights

Krishnaswamy Srinivas Raghavan is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing formulations that address critical medical needs.

Collaborations

He has collaborated with notable colleagues, including Timothy M Malloy and Sailesh A Varia, contributing to a dynamic research environment that fosters innovation.

Conclusion

Krishnaswamy Srinivas Raghavan's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His patents reflect a commitment to improving patient care through advanced drug delivery systems.

Profile summary based on public USPTO records.